bpc-157 pro tablets - 500mcg Rapid BPC-157 RAPID PRO - 500MCG

usually most pronounced during dose escalation Diarrhea : Affects 12-17% of patients, typically mild to moderate in severity Vomiting : Reported in 6-10% of patients, more common at higher doses Constipation : Occurs in 6-11% of patients Abdominal pain and dyspepsia : Generally transient Decreased appetite : An expected pharmacological effect contributing to weight loss Other documented adverse effects include injection site reactions, hypoglycemia (when used with insulin or sulfonylureas), and less commonly, fatigue

This direct route makes it incredibly effective, especially for anyone who struggles with absorbing B12 through their gut, such as those with pernicious anemia

Inflammatory tone is lower

While promising, these possibilities are still hypothetical until proper clinical trials are done